News InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 Staff September 11, 2023 Post Navigation Previous Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology TherapeuticsNext Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors More Stories Clinical Trial News Pharmaceutical Vaccine ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay Staff December 23, 2024 Clinical Trial News Pharmaceutical Vaccine ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay Staff December 23, 2024 EHR Healthcare News Patient Care Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships Staff December 23, 2024
